SomaLogic Secures $16,490,873 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=baa9d23c-d0dc-4ce9-aa9e-1f4da4b7b446 - Date
11/3/2014 - Company Name
SomaLogic - Mailing Address
2945 Wilderness Place Boulder, CO 80301 USA - Company Description
SomaLogic, Inc. is developing novel proteomics systems and applications based on its proprietary aptamer technology. Aptamers are single-stranded DNA and RNA molecules that, like antibodies, can bind to target molecules with high affinity and specificity. - Website
http://www.somalogic.com - Transaction Type
Venture Equity - Transaction Amount
$16,490,873 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
